This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Xencor, Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: John H. Stone: Innovator in Immunology
Introduction
John H. Stone is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of immunology, particularly in the treatment of IgG4-related diseases. With a total of 2 patents, his work has garnered attention in the scientific community.
Latest Patents
One of John H. Stone's latest patents is titled "Methods and Compositions for Inhibiting CD32B Expressing Cells in IgG4-Related Diseases." This patent focuses on immunoglobulins that bind to FcγRIIb+ B cells and coengage CD19 on the cell's surface. The methods described in this patent aim to provide innovative treatments for patients suffering from IgG4-related diseases.
Career Highlights
John H. Stone is currently associated with Xencor, Inc., where he continues to advance his research and development efforts. His work has been instrumental in exploring new therapeutic avenues in immunology.
Collaborations
Throughout his career, John has collaborated with esteemed colleagues, including Debra Zack and Shiv Pillai. These partnerships have further enriched his research and contributed to the success of his projects.
Conclusion
John H. Stone is a prominent figure in the field of immunology, with a focus on innovative treatments for IgG4-related diseases. His contributions through patents and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile